Mesoblast Limited vs iShares 0 3 Month Treasury Bond ETF — how do they compare? Mesoblast Limited trades at $17.03 (market cap $2.21B), while iShares 0 3 Month Treasury Bond ETF trades at $100.51. Which is the better fit depends on your goals.
| MESO | SGOV | |
|---|---|---|
Market Cap | $2.21B | — |
Sector | Technology | Fixed Income |
52-Week High | $20.96 | $100.74 |
52-Week Low | $12.88 | $100.28 |
Enterprise Value | $2.21B | — |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →